Orchestra BioMed Holdings, Inc. (OBIO) Revenue 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$33.5MFY2025 · since FY2022: $3.5M → $33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $33.5M | +1169.2% |
| FY2024 | $2.6M | -4.4% |
| FY2023 | $2.8M | -21.9% |
| FY2022 | $3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →